Survodutide hits where other weight loss drugs miss
Phase 3 data from the SYNCHRONIZE-1 trial shows the experimental drug reducing visceral and liver fat while preserving lean muscle mass in adults with obesity. Most weight loss medications work by suppressing appetite. Survodutide does that too, but the experimental drug developed by Boehringer Ingelheim is drawing attention for what it […]
Your gut bacteria may predict the best IBS treatment for you
Living with irritable bowel syndrome often means enduring a frustrating cycle: try a treatment, wait weeks for results, feel disappointed, and start all over again. Between 10% and 15% of U.S. adults are affected by the condition, and for many of them, finding relief feels less like medicine and more like guesswork. But a new […]
Injectable immunotherapy shrinks precancerous mouth lesions and spares patients from surgery
Injectable immunotherapy delivered directly into precancerous lesions in the mouth significantly reduced their size and helped the majority of patients avoid surgery, according to results from a phase I clinical trial presented at the American Association for Cancer Research Annual Meeting in April 2026. Roughly 5 percent of the general population carries precancerous lesions in […]